Winnipeg, MB
Apotex Fermentation Inc. is part of the Apotex Group of Companies, the largest Canadian-owned pharmaceutical group. The purpose of AFI is to discover and develop fermentation-based technologies for the production of Active Pharmaceutical Ingredients (APIs) and to manufacture APIs for eventual sale as final dosage forms in Canada and internationally. AFI is an advanced technology company utilizing state-of-the-art techniques for search and discovery, strain selection and improvement and bioprocess scale-up. AFI staff is highly qualified and trained in sophisticated chemical biological and pharmaceutical technologies. Our multimillion dollar facility in Southwest Winnipeg is the largest fermentation-based GMP facility in Canada.
50 Scurfield Blvd.
Winnipeg, MB R3Y 1G4
CA
50 Scurfield Blvd.
Winnipeg, MB R3Y 1G4
CA
Legal Name: Apotex Fermentation Inc.
Number of Employees: 150
CA
Fermenter sizes include 19, 150, 200, 1500, 14, 000 litres with reactor sizes to match to up to 8, 000 litres.
FDA Approved GMP Pharmaceutical manufacturer
46, 000 sq. ft. plant and lab area and 12, 000 sq. ft. engineering and administration
Production 70 R&D & Scale up 20 Engineering 20 QA/QC 20 Admin. 20
Title: Controller
Area of Responsibility: Domestic Sales & Marketing, Export Sales & Marketing, Management Executive, Finance/Accounting, Customer Service, Government Relations, Administrative Services
Phone: Show phone
Fax: Show fax
Email: Show email
Development of microbiological and chemical processes for the production of active pharmaceutical ingredients
Research and Development of fermentation based technologies in the pharmaceutical industry
Scale up of lab scale microbiological and chemical processes to commercial production scale processes for the manufacture of active pharmaceutical
Contract manufacturing of active pharmaceutical ingredients using fermentation based technologies under GMP
Bulk pharmaceutical product Cyclosporin USP
Bulk pharmaceutical product Pravastatin USP
325410
United States